✦ LIBER ✦

Cost Effectiveness Analysis of Boceprevir (BOC) Added to Pegifn/Ribavirin (P/R) Versus Pegifn/Ribavirin (Current Standard of Care) for the Treatment of Patients with Genotype 1 Chronic Hepatitis C in Greece

✍ Scribed by Athanasakis, K.; Karampli, E.; Retsa, M.P.; Theodoropoulou, T.; Kyriopoulos, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PIN29 Cost Effectiveness Analysis of Add

✍ Ramachandran, S.; Mahabaleshwarkar, R.; Yang, Y. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

COST-EFFECTIVENESS OF TELAPREVIR COMBINA

✍ Kaczor, M.P.; Wójcik, R.; Pawlik, D.; Skrzekowska-Baran, I.; Tronczynski, K. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

PGI18 Cost-Effectiveness of Boceprevir i

✍ S.C. Humphreys; E.H. Elbasha; S.A. Ferrante; M. Lion; C. O'Regan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PIN50 The Clinical Efficacy and Cost-Eff

✍ E. Nikoglou; S. Humphreys; A. El khoury; S.A. Ferrante; C. O' Regan 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PIN42 The Cost-Effectiveness of Telaprev

✍ Curtis, S.; Cure, S.; Bianic, F.; Gavart, S.; Dearden, L.; Fleischmann, J.; Ouwe 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PGI2 IS THERE ANY DIFFERENCE BETWEEN THE

✍ FMR Barros; H Cheinquer; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB